Brief Summary
Type:
Melanoma
Study Type:
Treatment
Phase:
II/III
ClinicalTrials.gov Identifier:
NCT02339571
Study #:
STUDY00149850
Start Date:
Mar 26, 2023
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT02339571
View Complete Trial Details & Eligibility at ClinicalTrials.gov
